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Abstract: Oligonucleotides carrying amino, thiol groups, as well as fluorescein, c-myc 
peptide sequence and nanogold at internal positions were prepared and used for the 
assembly of bidimensional DNA arrays. 
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1. Introduction  
In recent years the use of the self-assembly properties of DNA to generate addressable 
nanostructures has been extensively investigated [1–3]. DNA has many physical and chemical 
properties that make it a useful molecule for the assembly of nanostructures [1–3]. The solid-phase 
synthesis and the PCR amplification methods have made long and complex DNA molecules readily 
available in abundant quantities [4]. The relatively high physicochemical stability makes DNA easier 
to handle in normal laboratory conditions [1–4]. Synthetic modification of the bases, sugars and 3'-5'-
ends make it possible to add various functional groups at desired points [5]. 
A remarkable development in this field was the use of stable DNA Holliday junctions with 
addressable sticky ends to form two-dimensional DNA crystals [6]. The so-called “DNA-tile system” 
have since been used and adapted to generate systems with fine control of shape and function [6–10]. 
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More recently, origami DNA has been developed allowing large 2D structures using single-stranded  
7 kB long viral DNA held together by over 200 synthetic “staple” strands [11]. Origami DNA has been 
successfully assembled on photolitographically patterned substrates demonstrating a key step in the 
integration of bottom-up DNA assemblies with top-down microelectronics fabrication techniques [12]. 
We are interested in the site-specific functionalization of the DNA arrays with molecules and 
nanomaterials. In this direction, gold nanoparticles [13,14] and the c-myc [15] peptide have been 
introduced into the DNA tile system by using 5’-functionalized oligonucleotides. The resulting  
DNA-templated nanoparticle arrays are of potential interest in the manufacture of nanoscale integrated 
circuits for logic, memory, sensing and other applications [12,14]. Also the formation of DNA-
templated peptide epitope arrays may find application in the development of nanosensors [15]. As the 
ends of the oligonucleotides are used in the assembly of the array, this strategy involves: (1) an 
oligonucleotide involved in the formation of the DNA arrays; and (2) the use of a complex annealing 
step to ensure the incorporation of the small and modified oligonucleotide to the DNA lattice. 
Here we describe the formation of functionalized DNA arrays based on the Seeman’s DNA tile 
system [6] by direct functionalization of the internal positions of the oligonucleotides. Specifically, 
amino and thiol groups, as well as fluorescein, the c-myc peptide and nanogold were incorporated at 
selected internal positions of oligonucleotides. The resulting modified oligonucleotides were 
hybridized with the rest of the oligonucleotides yielding the desired DNA tiles. The amino and thiol 
groups have been selected as reactive groups in order to be further functionalized with compounds 
carrying carboxyl or maleimido groups. Fluorescein and the c-myc peptide sequence are model 
antigenic compounds that can be recognized by monoclonal antibodies. The DNA-templated array of 
fluorescein and the c-myc peptide antigens are intermediate steps for the fabrication of specific  
high-density monoclonal antibodies arrays which have potential interest for the development of 
nanobiochips [15]. Previously we demonstrated that chemical functionalization of DNA arrays with 
thiols direct the immobilization of DNA arrays to gold surfaces [16]. Here we demonstrate that DNA 
arrays can be used to template large ordered arrays of specific molecules of interest. 
2. Results and Discussion 
The aim of this work was the preparation of modified 2D DNA arrays. We focused on the A-B* tile 
system described by Winfree et al. [6] which comprises two DNA tiles, A and B*. Each tile is formed 
by the assembly of 5 oligonucleotides (A1–A5, B1–B5, Table 1). Tile B* has two loops protruding out 
of the plane of the DNA lattice in opposite directions. These two loops were used as topographic labels 
to indicate the position of tile B* on the DNA lattice during the process of visualization by atomic 
force microscopy (AFM). Figure 1 shows the formation of the unmodified DNA array using A-B* tile 
system [6]. As observed in Figure 1 (b) large arrays are formed which occupies a few micrometers. 
The position of the protruding DNA loops is clearly observed by AFM. We selected these loops for the 
introduction of the modifications as these loops are external and contain 4 unpaired thymidines, ideal 
for the introduction of the modifications. 
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Table 1. Sequences of oligonucleotides prepared. 
# Name Sequence (5’-3’) 
1 A1 GATGGCGACATCCTGCCGCTATGATTACACAGCCTGAGCATTGACAC 
2 A2 GTAGCGCCGTTAGTGGATGTC 
3 A3 TGTAGTATCGTGGCTGTGTAATCATAGCGGCACCAACTGGCA 
4 A4 GACTGCGTGTCAATGCTCACCGATGCAACCAG 
5 A5 CTGACGCTGGTTGCATCGGACGATACTACATGCCAGTTGGACTAACGG 
6 B1 CGCTACCGTGCATCATGGACTAACCAGTGCTCGCTGATTTTTCAGCGAGTTAC
CGCATCGGACTCGGACAGCAGC 
7 B2 CGTCAGGCTGCTGTGCTCGTGC 
8 B3 AGTACAACGCCACCGATGCGGTCACTGGTTAGTGGATTGCGT 
9 B4 GCCATCCGTCGATACGGCACCATGATGCACG 
10 B5 GCAGTCGCACGACCTGGCGTCTGTTGGCTTTTGCCAACAGTTTGTACTACGCA
ATCCTGCCGTATCGACG 
11 B1-amino CGCTACCGTGCATCATGGACTAACCAGTGCTCGCTGATTXTTCAGCGAGTTAC
CGCATCGGACAGCAGC; X = amino-dT 
12 B1-thiol CGCTACCGTGCATCATGGACTAACCAGTGCTCGCTGATTYTTCAGCGAGTTAC
CGCATCGGACAGCAGC, Y = t-butyldithio-ethyl-dC, t-butyldithio-ethyl-5-methyl-dC 
13 B5-thiol GCAGTCGCACGACCTGGCGTCTGTTGGCTTYTGCCAACAGTTTGTACTACGCA
ATCCTGCCGTATCGACG, Y = t-butyldithio-ethyl-dC, t-butyldithio-ethyl-5-methyl-dC 
14 B5-
fluorescein 
GCAGTCGCACGACCTGGCGTCTGTTGGCTTZTGCCAACAGTTTGTACTACGCA
ATCCTGCCGTATCGACG; Z = N-(fluorescein-maleimido-S-ethyl)-5-methyl-dC 
15 B5-c-myc 
peptide 
GCAGTCGCACGACCTGGCGTCTGTTGGCTTZTGCCAACAGTTTGTACTACGCA
ATCCTGCCGTATCGACG; Z = N-(c-myc-peptide-maleimido-S-ethyl)-5-methyl-dC; c-
myc peptide sequence: Maleimido-Ala-Glu-Gln-Lys-Leu-Ile-Ser-Glu-Glu-Asp-Leu-Asn-
CONH2 
16 B1-Nanogold CGCTACCGTGCATCATGGACTAACCAGTGCTCGCTGATTZTTCAGCGAGTTAC
CGCATCGGACAGCAGC, Z = N-(Nanogold-maleimido-S-ethyl)-dC 
Figure 1. The A-B* DNA tile system [6]. (a) Each tile is formed by 5 oligonucleotides that 
are represented in different colors. (b) Topological AFM image of the A-B* DNA lattice 
assembled on mica. Brighter (taller) diagonal ridges correspond to rows of the topological 
marker (hairpins present on tile B*) and fainter bands to DNA tile A. (c) Detailed AFM 
image of a small area of the DNA array. (d) 3-D image of the AFM image shown in Figure 
1(c) showing the lines of protruding hairpins used as topological markers. The apexes of 
these protruding hairpins have been selected to introduce selected chemical groups. 
a 
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2.1. Amino-Modified DNA Arrays 
Oligonucleotide 11 carrying one single amino group at the apex of the topological loops was 
prepared as shown in Scheme 1. Amino groups were selected due to their special reactivity as 
nucleophiles. This reactivity may be used for further functionalization with compounds carrying 
carboxyl groups. A phosphoramidite derivative of 2'-deoxyuracil carrying an amino alkyl group at 
position 5 of the uracil nucleobase was used to introduce the amino group at one specific site of 
oligonucleotide B1 (Table 1). The site of modification was one of thymidines forming the unpaired 
loop at the apex of one of the topological loops of tile B*. First a 20-base oligonucleotide containing 5 
amino-dT residues was prepared and the stability of this analogue in oligonucleotide synthesis 
conditions was confirmed by mass spectrometry analysis (Supplementary data). Then, oligonucleotide 
sequence 11 was synthesized and purified by denaturing gel electrophoresis. The purified 
oligonucleotide was hybridized with the rest of the oligonucleotides forming tile B* (B2–B4). DNA 
tile B* carrying one single amino group at the unpaired loop position was able to form correct B* 
DNA tile as observed by native gel electrophoresis analysis.  
Scheme 1. Steps used in the formation of the amino-modified A-B* DNA array. A 
phosphoramidite of the thymidine carrying an amino group is used to introduce the amino 
group at one specific site at the apex of one of the topological loops of tile B* described by 
Winfree et al. [6]. Annealing of the appropriate oligonucleotides yielded the desired DNA 
lattice that was then deposited on mica substrates. 
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Next, oligonucleotide sequence 11 was hybridized with the rest of the oligonucleotides A1-A5 (1–
5) and B2-B4 (7–10) yielding the desired DNA array that was then deposited on mica substrates. As 
can be seen from the AFM image in Figure 2a the DNA lattice carrying an amino group at the 
topological loop was observed on mica. The spacing of the decorated columns was 32 ± 1 nm, which 
was the same value observed in the bibliography for unmodified DNA lattices [6]. 
Figure 2. (a) Topological AFM image of the A-B* DNA lattice carrying amino groups 
assembled on mica. Brighter (taller) diagonal ridges correspond to rows of the topological 
marker (hairpins present on tile B*) and fainter bands to DNA tile A. (b) Topological AFM 
image of the A-B* DNA lattice carrying fluorescein groups assembled on mica. 
a b
m
 
2.2. Fluorescein-, c-myc Peptide- and Nanogold-Modified DNA Arrays 
Recently, the chemical functionalization of DNA arrays with thiols has been demonstrated [16]. The 
introduction of the thiol groups in the B1 and B5 DNA oligonucleotides was done using the strategy 
described above for the introduction of amino groups (Scheme 1). We used cytosine phosphoramidite 
derivatives for the introduction of the thiol groups protected with the t-butylthio group (Scheme 2). 
The use of the protected form of the thiol groups avoids the formation of undesired disulfide bonds. 
We modified tile B* by introducing one N4-[(t-butyldithio)ethyl]-dC or one N4-[(t-butyldithio)ethyl]-5-
methyl-dC residue to replace one thymidine residue at the unpaired loop positions of the 
oligodeoxynucleotides (Scheme 2). This involved preparing the two longer oligonucleotides of tile B* 
(69, 70 bases), which carry one single one N4-[(t-butyldithio)ethyl]-dC or one t-butyldithio-ethyl-5-
methyl-dC residue in the middle of the sequence. The appropriate phosphoramidites were synthesized 
as described [17,18]. Oligonucleotide sequences carrying thiol groups protected with the t-butylthio 
group (12, 13, Table 1) were purified by denaturing polyacrylamide gel electrophoresis (PAGE). The 
formation of the correct thiol-modified DNA arrays on mica have already been described [16].  
Next, we prepared oligonucleotides carrying fluorescein, c-myc peptide and nanogold at the apex of 
the topological loops (Scheme 2). Fluorescein and the c-myc peptide sequence were selected because 
they are model antigenic compounds that can be recognized by monoclonal antibodies. Nanogold was 
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selected as model gold nanoparticle. Maleimido derivatives of fluorescein and nanogold are 
commercially available. Maleimido- c-myc peptide was synthesized as described [17,18]. 
Scheme 2. Synthesis of oligonucleotides carrying fluorescein, c-myc peptide and nanogold 
at the apex of one of the topological loops of tile B* described by  
Winfree et al. [6]. 
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The synthesis of oligonucleotide conjugates carrying fluorescein (14) or c-myc peptide (15) started 
with the synthesis of thiolated oligonucleotide B5 (13, Table 1). This oligonucleotide was treated with 
tris(carboxyethyl)phosphine to remove the t-butylthio protecting group. The corresponding free thiol 
oligonucleotide was reacted with the corresponding maleimido derivatives as described [17–20] 
(Scheme 2) to yield the desired conjugates (14–15). Fluorescein and peptide conjugates 14 and 15 
were purified by gel electrophoresis (supplementary information). As oligonucleotides 14 and 15 are 
too long for mass spectrometry analysis, we set up the conjugation reactions with a shorter DNA 
sequence and the corresponding fluorescein and c-myc conjugates were obtained in good yields. The 
desired conjugates were characterized by mass spectrometry (supplementary information).   
The preparation of the nanogold conjugate 16 was slightly different. First thiolated oligonucleotide 
B1 (12, Table 1) was synthesized and purified by gel electrophoresis. The purified oligonucleotide 12 
was treated with 0.1 M dithiothreitol (DTT) overnight at 50 °C to remove the t-butylthio protecting 
group and the resulting thiolated oligonucleotide was incubated with maleimido-Nanogold. The 
resulting nanogold conjugate 16 was used directly from the conjugation reaction without further 
purification. The functionalization of the Nanogold with the desired oligonucleotide was confirmed by 
agarose gel electrophoresis [21]. 
DNA tiles B* formed with these conjugates were able to form correct tiles as observed by gel 
electrophoresis analysis of hybridized equimolar mixtures of the corresponding B1-B5 
oligonucleotides (supplementary information). Figure 2b shows the DNA lattices carrying fluorescein 
formed on mica. Figure 3 shows the arrays formed using nanogold-oligonucleotide conjugate 16. 
Nanogold was not observed as the size (around 1 nm) is similar to the size of double-stranded DNA. 
The observation of DNA arrays using peptide-oligonucleotide conjugate 15 on mica did not yield 
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positive results in spite of the good formation of B* tile observed by native gel electrophoresis. At 
present we do not know if the presence of the peptide sequence prevents the deposition of the array on 
mica or prevents the formation of large DNA arrays.  
Figure 3. (a) Topological AFM image of the A-B* DNA lattice carrying nanogold 
assembled on mica. Brighter (taller) diagonal ridges correspond to rows of the topological 
marker (hairpins present on tile B*) and fainter bands to DNA tile A. (b) 3-D image of the 
AFM image shown in 5 (a) showing the position of the topological markers. 
nm      
nm
 
(a)       (b) 
3. Experimental Section 
3.1. Oligonucleotide Synthesis 
Oligodeoxynucleotide sequences are shown in Table 1. The syntheses were performed on the 
Applied Biosystems Model 3400 DNA synthesizer using a scale of 0.2 µmol and standard  
2-cyanoethyl phosphoramidites as monomers. The N4-[(t-butyldithio)ethyl]-2'-deoxycytidine and N4-
[(t-butyldithio)ethyl]-5-methyl-2'-deoxycytidine phosphoramidites were prepared as described 
elsewhere [17,18]. After the addition of the N4-[(t-butyldithio)ethyl]-5-methyl-2'-deoxycytidine 
phosphoramidite, the oxidation solution used was a solution of tert-butyl hydroperoxide 10% in 
acetonitrile instead of the commercially available solution of iodine 0.02 M to avoid the oxidation of 
the thiol group described in reference [18]. The 5-amino-T-phosphoramidite was obtained from 
commercial sources. After the assembly of sequences, ammonia deprotection was performed overnight 
at 55 °C. Oligonucleotides were purified by polyacrylamide gel electrophoresis (PAGE) (see below). 
Purification of oligonucleotides by HPLC using DMT-on protocols yielded oligonucleotides that were 
not pure enough to generate complete DNA arrays (Supplementary section).   
3.2. Preparation of DNA-Conjugates 
Oligonucleotide sequence 13 was used to perform the reactions with fluorescein diacetate  
5-maleimide, and maleimido c-myc peptide prepared as described [17]. For the preparation of each 
conjugate 50 OD260 units of crude oligonucleotide 13 were used. To cleave the disulfide bond, 
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oligonucleotide 13 was dissolved in 1 mL of 0.1M triethylammonium acetate solution (pH = 7). 
Afterwards, 40 μL of a 0.5 M tris(2-carboxyethyl)phosphine hydrochloride (TCEP. HCl) solution were 
added to the solution and allow to react at 55 °C overnight. Under these conditions, the tert-butylthiol 
group was completely removed [18,19]. The resulting product was purified with Sephadex G-25 
(NAP-10 column). The oligonucleotide carrying the free thiol group was eluted with 1.5 mL of  
sterile water.  
Conjugation with fluorescein: To the resulting solution, 150 μL of a 1M triethylammonium acetate 
solution were added. Then, 100 μL of a solution 33 mM fluorescein diacetate 5-maleimide in DMF 
were added and allowed to react at room temperature overnight. The crude oligonucleotide was 
concentrated to dryness and then dissolved in 400 μL of a 0.2 M sodium hydrogen carbonate solution 
(pH = 9). The solution was heated at 55 °C for 1 h. Then 600 μL of sterile water were added and the 
excess of reagents and salts were removed by using a NAP-10 column. The oligonucleotide was eluted 
with 1.5 mL of sterile water and was purified by polyacrylamide gel electrophoresis (PAGE)  
(see below). 
Conjugation with c-myc-peptide: To the resulting solution, 200 μL of a 1M triethylammonium 
acetate solution were added. Then, 500 μL of a solution 24 mM of the maleimido peptide [17,18,20] in 
sterile water were added. The pH was adjusted to 6 and the mixture was allowed to react at room 
temperature overnight. The crude oligonucleotide was concentrated to dryness and the excess of 
reagents and salts were removed by using a NAP-10 column. The oligonucleotide was eluted with  
1.5 mL of sterile water and purified by polyacrylamide gel electrophoresis (PAGE) (see below). 
Conjugation with maleimido-nanogold: Oligonucleotide sequence 12 was used to perform the 
conjugation with maleimido-Nanogold. First, thiolated oligonucleotide 12 was purified by 
polyacrylamide gel electrophoresis (PAGE) (see below). Then, the purified oligonucleotide was treated 
with 0.1 M dithiothreitol (DTT) overnight at 50 °C to remove the t-butylthio protecting group. The 
excess of DTT was removed by filtration over a NAP-10 column (Sephadex G-25). The desired thiol-
oligonucleotide was eluted in 1 mL solution that was concentrated to 0.3 mL. The resulting thiolated 
oligonucleotide was incubated with commercially available maleimido-Nanogold. The resulting 
nanogold conjugate 16 was used directly from the conjugation reaction without further purification. 
The functionalization of the Nanogold with the desired oligonucleotide was confirmed by the presence 
of a brown spot in 3% agarose gel electrophoresis as described in reference [21].  
3.3. Oligonucleotide Purification 
Oligodeoxynucleotides were purified using denaturing gel electrophoresis.  The gels contained 20% 
acrylamide (19:1, acrylamide/bisacrylamide) and 8.3 M urea, and were run at 55 °C on a Hoefer SE 
600 electrophoresis unit. The running buffer comprised 89 mM Tris base, 89 mM boric acid, and  
2 mM EDTA at pH 8.0. The sample buffer contained 10 mM NaOH, 1 mM EDTA, and a trace amount 
of Xylene Cyanol FF tracking dye. Gels were stained with ethidium bromide and the target band was 
excised and eluted in a solution containing 500 mM ammonium acetate, 10 mM magnesium acetate, 
and 1 mM EDTA. The eluates were extracted with n-butanol, which removes the ethidium bromide, 
followed by ethanol precipitation. 
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3.4. Formation of Hydrogen-Bonded Complexes and DNA Arrays 
Complexes were formed by mixing a stoichiometric quantity of each strand, which was estimated 
by measuring the optical density at 260 nm. All 10 strands (A1-A5 and B1-B5) were mixed in 10 mM 
HEPES (pH 7.8), 12 mM MgCl2, and 2 mM EDTA. The final concentration of DNA was 0.2–0.4 M. 
The final volume was 50 µL. Mixtures were annealed from 90 °C to room temperature for 40 h in a  
2 litre water bath insulated in a styrofoam box. Previous to the array formation the correct assembly of 
tile A and modified tile B* was checked by nature PAGE. 
3.5. Atomic Force Microscopy (AFM) Imaging 
A sample of between 2–7 µL was spotted on freshly cleaved mica (Ted Pella, Inc.). The arrays were 
imaged in tapping mode in a buffer. The sample was deposited for 1–3 min and an additional 35 µL of 
fresh buffer was added to the liquid cell. All AFM imaging was performed on a NanoScope III (Digital 
Instruments) or Asylum MFP3D using commercial cantilevers with Si3N4 tips.  
4. Conclusions  
The preparation of long DNA sequences carrying thiol- and amino reactive groups in the internal 
positions is described. These oligonucleotides have been used for the preparation of oligonucleotide 
conjugates carrying fluorescein, peptides and nanogold at internal positions. The modified 
oligonucleotides were key elements for the formation of bidimensional DNA arrays carrying the 
molecule or nanomaterial of interest at the external B* loops. Although the observation of all the 
functionalized DNA arrays on mica have not been possible, we show that the long DNA sequences 
functionalized at a specific site can be prepared and the approach described is potentially interesting 
for the construction of DNA-mediated periodic arrays of selected molecules and nanomaterials at the 
nanoscale. The results described in this work may also be of interest for the preparation of 
functionalized DNA origamis [11,12]. This method relies on the use of a long single-stranded viral 
DNA and the length of the staple oligonucleotides is relatively short (between 30–40 bases) as well as 
the degree of purity is less demanding than the synthetic oligonucleotides used for the preparation of 
two-dimensional arrays. Work in this direction is currently ongoing. 
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